The estimated 2017 U.S. prevalence of individuals with amyotrophic lateral sclerosis (ALS) was 24,821, or 7.7 per 100,000 people,…
Lindsey Shapiro, PhD
Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Lindsey Shapiro, PhD
A research team has developed a new way to search for genes and gene mutations that may contribute to the…
Merit E. Cudkowicz, MD, is the winner of the inaugural Target ALS Rebecca Luker Courage Award in recognition…
Note: Frontiers in Genetics, the publisher of the study discussed in this ALS News Today news story, received a request…
Occupational exposure to lead — a heavy metal — prior to disease onset is associated with a more severe disease…
Blocking channels containing the connexin 43 (Cx43) protein on astrocytes — a type of nerve support cell — slowed disease…
A first healthy volunteer has been enrolled in a Phase 1 trial and given a first dose of PrimeC,…
ALPHA-0602, an investigational gene therapy for amyotrophic lateral sclerosis (ALS), can successfully increase progranulin levels and reduce the toxicity…
Team Drea Foundation is launching a customizable wellness challenge that seeks to raise $50,000 in 50 days for…
Minnesota lawmakers have passed legislation that will provide $25 million for amyotrophic lateral sclerosis (ALS) research and to support ALS…